Ovarian Cancer Treatment

Ovarian Cancer Treatment Without Surgery

_____________________________

Schedule Consultation

– Start Online Consultation

If you or your loved one is exploring Ovarian Cancer Treatment Without Surgery, early medical evaluation is important. Fuda Cancer Centre supports patients across India with advanced non-surgical cancer treatment options. There is no need to visit the hospital initially — simply take an online consultation from home.

Our expert Dr. Anup Aboti will review your PET/CT scans, biopsy reports, blood investigations, and complete medical history to determine the most suitable non-surgical ovarian cancer treatment plan for your condition. Fill out the form to schedule your online consultation today.

Start Online Consultation →
Fuda Cancer Hospital

Ovarian Cancer Treatment Without Surgery offers advanced non-surgical treatment approaches for selected patients diagnosed with ovarian cancer. Patients across India can receive expert evaluation through online consultation before planning treatment. Modern therapies focus on controlling cancer growth, improving quality of life, and reducing the need for major surgical procedures whenever possible.

What Is Ovarian Cancer Treatment Without Surgery?

Non-surgical ovarian cancer treatment includes advanced medical therapies used to manage ovarian cancer without immediate surgery. Depending on the stage, spread, and overall patient condition, doctors may recommend targeted therapy, chemotherapy, immunotherapy, HIPEC-based planning, or supportive cancer care.

Treatment aims to shrink tumours, slow disease progression, relieve symptoms, and improve patient outcomes while minimising physical stress associated with major surgery.

Why Non-Surgical Treatment Is Gaining Attention

  • May help avoid major surgery in selected patients
  • Suitable for elderly or medically unfit patients
  • Supports advanced or metastatic ovarian cancer management
  • Can reduce tumour burden before future procedures
  • Focuses on personalised cancer care
  • May improve quality of life and symptom control

Many patients explore non-surgical treatment options when surgery is high-risk, delayed, or not immediately possible.

Who May Benefit From Non-Surgical Treatment

Doctors carefully evaluate imaging scans, pathology reports, blood tests, and overall health before recommending treatment without surgery. It may be considered for:

  • Advanced ovarian cancer
  • Patients unfit for major surgery
  • Recurrent ovarian cancer
  • Metastatic disease
  • Patients seeking less invasive treatment approaches
  • Individuals requiring tumour control before surgery

Comprehensive medical evaluation is essential before finalising any treatment plan.

Treatment Options Without Surgery

  • Chemotherapy
  • Targeted therapy
  • Immunotherapy
  • Hormone therapy
  • Precision oncology approaches
  • Palliative and supportive cancer care

Treatment Timeline & Recovery

Initial Evaluation

  • Review of PET/CT scans and reports
  • Blood investigations and tumour markers
  • Personalised treatment planning

During Treatment

  • Scheduled therapy sessions
  • Regular monitoring and follow-up
  • Symptom management and supportive care

Recovery & Monitoring

  • Periodic imaging scans
  • Treatment response assessment
  • Long-term cancer monitoring

Recovery and treatment response vary depending on cancer stage and individual patient health.

Benefits of Non-Surgical Ovarian Cancer Treatment

  • Less invasive compared to surgery
  • Reduced hospital stay
  • Personalised treatment planning
  • Supportive symptom management
  • Improved treatment flexibility
  • Online consultation and remote evaluation available

Treatment Comparison

Treatment Approach Recovery Invasiveness
Non-Surgical Therapy Medical / targeted treatment Moderate Minimally invasive
Surgery Tumour removal procedure Longer Highly invasive
Chemotherapy Systemic cancer treatment Variable Non-surgical
Targeted Therapy Precision cancer treatment Shorter Low invasive impact

How to Choose the Right Cancer Centre

  • Experienced oncology specialists
  • Advanced imaging and diagnostic facilities
  • Multidisciplinary cancer care team
  • Personalised treatment planning
  • Comprehensive follow-up support

How Indian Patients Can Get Started

Patients can share PET/CT scans, pathology reports, biopsy findings, and medical history online for expert review. Doctors provide treatment guidance, eligibility evaluation, and personalised recommendations before any hospital visit.

Benefits for Indian Patients

  • Online consultation from home
  • Access to advanced cancer treatment options
  • Reduced need for immediate surgery
  • Personalised medical guidance
  • Comprehensive follow-up care
  • Support throughout the treatment journey

Modern ovarian cancer treatment without surgery focuses on personalised care, advanced medical therapies, and improving patient quality of life. Specialists develop customised treatment plans based on the individual condition and treatment goals of each patient.

Alternatives & When They Fit Better

PRRT is a highly specialised treatment designed for specific neuroendocrine tumours. However, it is not always the first treatment choice. Doctors evaluate tumour biology, disease stage, receptor status, and patient health before deciding the best approach.

  • Somatostatin Analog Therapy – Often preferred for slow-growing tumours and long-term symptom control
  • Targeted Therapy – Suitable when tumours show specific molecular features
  • Chemotherapy – Considered for aggressive or rapidly progressing disease
  • Surgery – Best for localised tumours that can be safely removed
  • Radiation Therapy – Used for local tumour control or symptom relief

PRRT is typically recommended when tumours are somatostatin receptor-positive and disease progression requires a targeted systemic therapy.

Latest Updates & What’s Changing

PRRT continues to advance with improvements in nuclear medicine technology and clinical protocols. These developments aim to enhance treatment precision and patient safety.

  • More accurate PET/CT imaging for better patient selection
  • Refined dosing strategies to optimise effectiveness
  • Improved kidney protection techniques
  • Enhanced monitoring of bone marrow function
  • Better management of therapy-related side effects

Ongoing research focuses on improving long-term outcomes and identifying the most effective treatment combinations.

Key Differences: Side-by-Side

Treatment Main Purpose Targeting Precision Body Impact
PRRT (Lu-177) Deliver radiation directly to tumour cells Highly targeted Focused therapeutic effect
Chemotherapy Destroy rapidly dividing cells Broad Systemic effects
Targeted Therapy Block cancer growth pathways Moderate to high Drug-specific effects
Surgery Remove tumour mass Localised Invasive procedure

Each treatment serves a distinct clinical role. Many patients receive multiple therapies during the course of their disease.

Cost & Ongoing Needs

PRRT is a complex nuclear medicine therapy requiring specialised facilities, trained experts, and strict safety protocols. Treatment costs vary depending on patient condition and institutional practices.

  • Therapy is delivered in multiple cycles
  • Requires specialised radioactive medication (Lu-177)
  • Includes imaging and laboratory assessments
  • Regular blood tests are essential
  • Follow-up scans are required
  • Long-term monitoring is recommended

Patients should discuss treatment planning, monitoring requirements, and financial considerations with their healthcare team.

Preparing for PRRT Treatment

Careful preparation improves both safety and treatment effectiveness. Doctors provide personalised guidance based on clinical evaluation.

  • Review of PET/CT imaging and receptor studies
  • Blood tests for kidney and bone marrow function
  • Assessment of previous treatments
  • Medication adjustments if necessary
  • Hydration recommendations
  • Radiation safety instructions

Understanding the preparation process helps patients feel more confident and informed.

Long-Term Outcomes and Survival Rates

Treatment outcomes vary widely depending on tumour biology, disease burden, receptor expression, and patient health. PRRT is designed to slow tumour progression and improve quality of life.

  • Disease stabilisation is frequently observed
  • Some patients experience tumour reduction
  • Symptom improvement is common
  • Response duration varies between individuals
  • Long-term follow-up is essential

Doctors provide individualised expectations based on imaging findings and overall clinical assessment.

Why Choose Fuda Cancer Hospital for PRRT (Lu-177 Dotatate) Treatment?

Advanced nuclear medicine expertise, precision-targeted therapy, and structured patient support for individuals across India.

Extensive Clinical Experience in PRRT with Dedicated Indian Consultation Support
Fuda Cancer Hospital has significant experience in administering PRRT (Lu-177 Dotatate) for eligible neuroendocrine tumour cases. Indian patients can begin with an online consultation, where PET/CT scans, pathology reports, and treatment history are carefully reviewed. Doctors provide clear, realistic guidance before any treatment planning or travel decisions.
Personalised PRRT Planning Based on Receptor Imaging & Disease Behaviour
PRRT is a highly targeted radionuclide therapy designed for tumours expressing somatostatin receptors. Each treatment plan is customised based on receptor imaging, tumour spread, prior treatments, organ function, and overall patient health — ensuring precision, safety, and clinical appropriateness.
Integrated Treatment Strategies for Complex Neuroendocrine Tumours
Depending on the clinical scenario, PRRT may be integrated with Somatostatin Analog Therapy, Targeted Therapy, Chemotherapy, or other supportive treatments. This multidisciplinary approach helps optimise disease control while prioritising patient safety and quality of life.
Expert Evaluation for Advanced, Recurrent, or Metastatic Disease
Many patients consider PRRT when tumours progress despite standard therapies. Through detailed case analysis, specialists provide evidence-based recommendations, helping patients and families understand realistic treatment expectations without unnecessary interventions.
Structured Monitoring & Long-Term Follow-Up Support
PRRT requires careful monitoring of kidney function, bone marrow health, and tumour response. Patients receive structured follow-up guidance, imaging reviews, and ongoing consultation support — ensuring continuity of care even after returning home.
PRRT (Lu-177 Dotatate) Treatment – Patient Reviews

PRRT (Lu-177 Dotatate) Treatment

Real patient experiences sharing their PRRT treatment journey, symptom management, and follow-up outcomes.

★★★★★

Neuroendocrine Tumour – Disease Stabilised

After multiple treatments, doctors recommended PRRT. The evaluation process was detailed and reassuring. Follow-up scans showed stable disease, and symptoms improved gradually.
Patient
★★★★★

Liver Metastases – Targeted Therapy Helped

PRRT was advised after tumour progression. Doctors explained expectations clearly. Fatigue was manageable, and later imaging showed good response.
Patient’s Daughter
★★★★★

Online Consultation – Clear Eligibility Guidance

We shared PET/CT scans online. Doctors carefully reviewed receptor imaging and blood tests. The guidance was honest and easy to understand.
Family Member
★★★★★

Advanced NET – Symptom Relief Achieved

Hormone-related symptoms were affecting daily life. PRRT helped control symptoms over time. The monitoring process felt very structured.
Patient
★★★★★

Progressive Disease – Balanced Expectations

Doctors explained both benefits and limitations. Treatment decisions felt transparent. Side effects were manageable with proper care.
Patient’s Husband
★★★★★

Multiple Cycles – Smooth Treatment Experience

Treatment cycles were organised and well-monitored. Blood tests and scans were reviewed regularly. Overall experience was reassuring.
Patient
★★★★★

Second Opinion – Evidence-Based Advice

Doctors reviewed all previous treatments. The explanation of PRRT suitability was clear and realistic. This helped us decide confidently.
Patient’s Brother
★★★★★

Metastatic NET – Quality of Life Improved

Fatigue and discomfort reduced gradually after PRRT cycles. Regular monitoring helped track progress and maintain confidence.
Patient
★★★★★

Structured Monitoring – Reassuring Care

Kidney and blood parameters were monitored closely. Doctors explained every step. The treatment journey felt safe and well-managed.
Patient’s Family
★★★★★

Overall Experience – Compassionate Support

Beyond treatment, emotional guidance and realistic counselling made a significant difference for our family.
Family Member

PRRT (Lu-177 Dotatate) Treatment

Advanced targeted radionuclide therapy designed for eligible neuroendocrine tumours (NETs), focusing on precision treatment, disease control, symptom management, and preservation of quality of life for patients across India.

What Is PRRT (Lu-177 Dotatate)?
  • PRRT (Peptide Receptor Radionuclide Therapy): A highly specialised nuclear medicine treatment used for tumours that express somatostatin receptors. The therapy combines a targeting molecule with a radioactive isotope (Lu-177).
  • Once administered, the treatment binds specifically to tumour cells and delivers focused radiation directly to the cancer.
  • This targeted approach helps slow tumour progression while minimising exposure to surrounding healthy tissues.
  • PRRT is delivered in multiple treatment cycles and requires careful clinical monitoring.
  • The therapy may be integrated with other treatments depending on tumour behaviour and patient condition.
Conditions Commonly Treated with PRRT
  • Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETs)
  • Pancreatic Neuroendocrine Tumours
  • Small Intestine Neuroendocrine Tumours
  • Lung Neuroendocrine Tumours
  • Metastatic Neuroendocrine Tumours
  • Progressive Somatostatin Receptor-Positive Tumours
  • Recurrent Neuroendocrine Tumours
  • Symptomatic Hormone-Secreting Tumours
Why PRRT Is Important for Patients in India

PRRT offers a valuable treatment option for patients with somatostatin receptor-positive neuroendocrine tumours, particularly when disease progression continues despite conventional therapies.

The therapy is designed to deliver radiation precisely to tumour cells, helping achieve disease stabilisation and symptom control while reducing systemic treatment burden.

PRRT is often considered for patients with advanced or metastatic disease, recurrent tumours, or those requiring a highly targeted treatment approach.

With structured monitoring and follow-up, PRRT supports long-term disease management and helps maintain patient comfort and quality of life.

Frequently Asked Questions – PRRT (Lu-177 Dotatate)

Common questions patients ask about PRRT therapy, eligibility, safety, and treatment planning

What is PRRT (Lu-177 Dotatate) treatment?

PRRT (Peptide Receptor Radionuclide Therapy) is a highly targeted nuclear medicine treatment used primarily for somatostatin receptor-positive neuroendocrine tumours (NETs). The therapy delivers focused radiation directly to tumour cells while minimising exposure to surrounding healthy tissues.

Which patients are eligible for PRRT?

PRRT is recommended for patients whose tumours show somatostatin receptor positivity on specialised imaging such as PET/CT scans. Doctors also evaluate tumour behaviour, prior treatments, kidney function, bone marrow health, and overall clinical condition before recommending therapy.

Is PRRT a chemotherapy treatment?

No. PRRT is not chemotherapy. It is a targeted radionuclide therapy designed to deliver radiation directly to tumour cells. Unlike conventional chemotherapy, PRRT works through receptor-based targeting rather than affecting all rapidly dividing cells.

How is PRRT treatment administered?

PRRT is administered through an intravenous infusion. The therapy is usually delivered in multiple treatment cycles, spaced several weeks apart. Patients are monitored carefully during and after each cycle.

What are the possible side effects of PRRT?

Most patients tolerate PRRT well. Some individuals may experience temporary fatigue, mild nausea, or changes in blood parameters. Kidney function and bone marrow health are monitored closely to ensure treatment safety.

How many PRRT cycles are required?

The number of cycles varies depending on tumour response, clinical protocols, and patient condition. Doctors determine the treatment schedule based on imaging results, laboratory tests, and overall therapeutic goals.

Can PRRT be combined with other treatments?

Yes. PRRT may be integrated with Somatostatin Analog Therapy, targeted therapy, chemotherapy, or supportive care strategies depending on tumour behaviour and disease progression.

Is PRRT suitable for advanced or metastatic tumours?

PRRT is commonly considered for advanced or metastatic neuroendocrine tumours that express somatostatin receptors, especially when disease progression occurs despite conventional treatments.

How can patients begin PRRT evaluation?

Patients can begin with an online consultation by sharing PET/CT scans, pathology reports, and previous treatment records. Specialists review the case carefully and provide personalised guidance before any treatment planning.

Our Specialties & Procedures

Explore our range of advanced cancer care procedures designed to provide comprehensive treatment and improve your well-being.

Cancer Icon

Advanced Therapies For Cancer

Innovative and precise cancer treatments combining advanced technology, targeted therapy, and personalized medicine for better recovery outcomes.

Explore More →
Cancer Icon

Treating Specific Cancer

Specialized treatment plans for different cancer types — including liver, lung, breast, and bone cancers — with a focus on patient comfort and long-term wellness.

Explore More →

Our Specialties & Procedures

Explore our range of advanced cancer care procedures designed to provide comprehensive treatment and improve your well-being.

Cancer Icon

Advanced Therapies For Cancer

Innovative and precise cancer treatments combining advanced technology, targeted therapy, and personalized medicine for better recovery outcomes.

Explore More →
Cancer Icon

Treating Specific Cancer

Specialized treatment plans for different cancer types — including liver, lung, breast, and bone cancers — with a focus on patient comfort and long-term wellness.

Explore More →

ABOUT FUDA CANCER HOSPITAL

OUR ACHIEVEMENTS

Achievements of FUDA CANCER HOSPITAL

50+ Doctors

Professional Experts

1200+ Patients

Happy Indian Patients

100+ Countries

Global Presence

500+ Employees

Dedicated Workforce

Advanced Therapies for Cancer of All Stages

Nano Knife IRE (Irreversible Electroporation)

Cryotherapy | Cryosurgery | Cryo-ablation

Brachytherapy for Cancer

Microvascular Interventional Chemotherapy

Patient Testimonials

Mrs. Pratibha Rajgopal

Mrs. Dipikabehan Parmar

Mrs. Roseline Chandran

Mrs. Jyoti Bhatia

Scroll to Top